Body-identical Hormone Replacement Therapy
This article discusses the novel body-identical progesterone compared to other hormone replacement therapies and its place in the treatment of menopause.
Written by Dr John Eden MB BS MD FRCOG FRANZCOG CREI
Dr John Eden is a certificated reproductive endocrinologist and gynaecologist. He is a Conjoint Associate Professor at The University of New South Wales in Sydney. He is a visiting medical officer at the Royal Hospital for Women, Sydney, Australia where he is Director of the Sydney Menopause Centre and the Barbara Gross Research Unit. He also works at the Moree Aboriginal Health Service and is a Director of the Women’s Health and Research Institute of Australia (WHRIA). His research and clinical interests include managing menopause after breast cancer, infertility, early menopause, polycystic ovary syndrome (PCOS), amenorrhoea, osteoporosis, PMDD, biofilms, hormone replacement therapy as well as herbal medicine.